- The Thermocool SmartTouch SF Catheter is intended to treat patients with heart rhythm disorders.
- Israel-based EyeYon developed a new contact lens designed to treat corneal edema.
- Two heart valves, created by Irvine, Calif.-based Edwards Lifesciences, received clearance for expanded indications.
- Belgium-based Ion Beam Applications developed a new super conducting accelerator for its intensity modulated proton therapy system to treat patients with cancer.
More articles on supply chain:
Valeant investor sues drug company over ‘fraudulent scheme’
10 healthcare supply chain management apps to know
FDA approves expanded indications of heart valve
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
